Furthermore, the results of KEGG pathway enrichment analysis further demonstrated that CHRDL1 and its co-expressed genes were enriched in the pathway in cancer, phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway, cytokine-cytokine receptor interaction, focal adhesion and others (Fig. 14D). The gene discussed is AKT1; the disease is cancer.